FDA Drug recall D-1226-2014
Demerol, meperidine HCL Inj
- FDA Drug
- Class III
- terminated
- Published 2014-04-16
On 2014-04-16 the FDA classified a Class III recall of Demerol, meperidine HCL Inj by Hospira, citing labeling; Missing label; ampoules are missing the immediate container label.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1226-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-03-25 |
| Published | 2014-04-16 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.
Reason
Labeling; Missing label; ampoules are missing the immediate container label
Identifiers
| code_info | Lot: 221303A, 1OCT2014 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1226-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.